Cancer
INDICATION: Non-small cell lung cancer (NSCLC)
Cell culture and mouse studies suggest modulating SF3B1-mediated splicing alone or in combination with BCL-2 and Bcl-XL
Gathering data...
INDICATION: Non-small cell lung cancer (NSCLC)
Cell culture and mouse studies suggest modulating SF3B1-mediated splicing alone or in combination with BCL-2 and Bcl-XL